Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000685695 | SCV000813187 | pathogenic | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-03-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 565995). This premature translational stop signal has been observed in individual(s) with autosomal dominant episodic ataxia 2 (PMID: 30852237). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg1432*) in the CACNA1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CACNA1A are known to be pathogenic (PMID: 10371528, 19486177, 25735478, 27250579). |
Centre de Biologie Pathologie Génétique, |
RCV002274087 | SCV002558940 | likely pathogenic | Neurodevelopmental delay | criteria provided, single submitter | clinical testing |